Replies to post #2689 on ScripsAmerica Inc. (SCRCQ)

[W4Rnerv]

I'll buy your shares in a heartbeat...

[StockBull]

Welcome to the board Mouthhee. I believe this is only going higher in my honest opinion, too much going for SCRC for this to start moving lower. People will scoop up shares and wait to start selling at least at a $1, this is a $1.50-$2.00 worthy stock. Might even get up-listed in the future with the moves Mr. Schneiderman is making for the company and its shareholders.

[tutter18]

Welcome to the SCRC board Mouthhee!!!!! Tut

[TheFinalCD]

ScripsAmerica Enters Agreement With DPG Distribution for the Exclusive Representation of RapiMed(R) Throughout North America



Scripsamerica (OTCBB:SCRC)
Intraday Stock Chart

Today : Wednesday 26 June 2013
Click Here for more Scripsamerica Charts.

ScripsAmerica Inc. (OTCBB:SCRC), a supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has entered into a Representation Agreement with DPG Distribution ("DPG") for the exclusive right to purchase, promote and resell its RapiMed® OTC products throughout North America, commencing with its children's pain reliever and fever reducer.

The Agreement has a term of two years and contains a provision whereby its exclusivity is subject to DPG meeting designated sales quotas for RapiMed®. DPG Distribution offers worldwide sales, marketing and distribution services for high-end retail consumer products. The company calls on some of the largest retail chains in the world such as Wal-Mart, Costco, Target, Walgreens, CVS and ShopRite.

ScripsAmerica's CEO, Bob Schneiderman, commented, "ScripsAmerica is extremely proud and pleased to announce this agreement, which we believe has tremendous growth implications for our company and its shareholders. DPG Distribution's network of clients is not only tremendous in size and quality, but it contains some of the world's largest retailers who are at the pinnacle of our target market."

"By working with DPG, ScripsAmerica is now able to maximize our large-scale national market opportunities for RapiMed® Children's Pain Reliever and Fever Reducer. We expect this development to have a profound and positive impact on the success of RapiMed®'s product launch as well as its ongoing sales and market penetration," continued Schneiderman.

Gordon Jones, Chief Operating Officer of DPG Distribution, added, "DPG is very excited to represent RapiMed® in the North American market. RapiMed® has the potential to experience great success penetrating the massive market for children's pain relievers because of its speed, effectiveness, dosing accuracy and safety. Currently, we believe a very large opportunity exists for a new, superior product like RapiMed® to be introduced and capture significant market share. DPG looks forward to a long and profitable partnership with ScripsAmerica."

ScripsAmerica anticipates launching its RapiMed® product in September of this year into retail, food and drug store chains with plans to expand its distribution avenues.

About DPG Distribution

DPG Distribution is a distributor of high-end retail consumer products, offering worldwide service in sales, marketing, distribution and in-store support in all significant channels including academic, state and federal government, military, large to small consumer retailers, online merchants and rent to own channels. Initially focused on North America, DPG is now expanding its business to Latin and South America as well as Europe. For more information, visit www.dpgdistribution.com.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies.

For more information, visit www.ScripsAmerica.com.